{"gene":"POR","run_date":"2026-06-10T06:43:35","timeline":{"discoveries":[{"year":2020,"finding":"POR (NADPH-cytochrome P450 reductase) transfers electrons from NADPH to oxygen to generate hydrogen peroxide, which reacts with iron to produce reactive hydroxyl radicals that peroxidize polyunsaturated fatty acid chains of membrane phospholipids, causing membrane disruption during ferroptosis. Genetic knockout of POR decreases cellular hydrogen peroxide generation, preventing lipid peroxidation and ferroptosis. POR knockdown in mouse liver also prevents ConA-induced liver damage.","method":"Genetic knockout (CRISPR), hydrogen peroxide measurement, lipid peroxidation assays, mouse liver knockdown model","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (genetic KO, biochemical H2O2 assay, lipid peroxidation, in vivo mouse model), replicated mechanistic pathway","pmids":["33321093"],"is_preprint":false},{"year":2021,"finding":"POR (NADPH-cytochrome P450 reductase) and CYB5R1 oxidoreductases directly peroxidize PUFA phospholipids in protein-free liposomes in a cell-free reconstitution assay, demonstrating intrinsic enzymatic capacity for lipid oxidation independent of cellular context.","method":"Cell-free liposome assay, Tb3+ liposome release, electron microscopy","journal":"STAR protocols","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with purified components in defined liposome system, confirming mechanistic finding from PMID 33321093","pmids":["33718888"],"is_preprint":false},{"year":1989,"finding":"Human NADPH-cytochrome P450 oxidoreductase (POR/CYPOR) encodes a 677 amino acid microsomal protein; vaccinia virus-expressed POR was enzymatically active in reducing cytochrome c and stimulated CYP3 (P450)-mediated ethoxycoumarin O-deethylase and aryl hydrocarbon hydroxylase activities when co-expressed with human CYP3. The CYPOR gene was mapped to chromosome 7 (7p15-q35).","method":"Vaccinia virus heterologous expression, cytochrome c reduction assay, co-infection enzymatic assay, somatic cell hybrid mapping","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct enzymatic reconstitution with expressed protein; functional CYP stimulation demonstrated in co-infected cells","pmids":["2501655"],"is_preprint":false},{"year":2004,"finding":"Compound heterozygous loss-of-function mutations in POR (including R454H in the FAD-binding domain) cause Antley-Bixler syndrome with impaired steroidogenesis, demonstrating that POR is the obligate electron donor for multiple steroidogenic P450 enzymes (17α-hydroxylase, 17,20-lyase, 21-hydroxylase, lanosterol 14α-demethylase).","method":"Direct sequencing of patient DNA, identification of mutations in FAD-binding domain, clinical phenotype-genotype correlation","journal":"American journal of medical genetics. Part A","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — human genetics with functional domain annotation; mechanism inferred from conserved FAD-binding domain disruption and clinical steroidogenesis defects; single study without in vitro reconstitution","pmids":["15264278"],"is_preprint":false},{"year":2010,"finding":"POR transports electrons from NADPH to all microsomal cytochrome P450 enzymes including steroidogenic P450c17, P450c21 and P450aro. Characterization of ~40 POR variants showed that assays based on P450c17 activities (but not cytochrome c assays) correlate with clinical ABS phenotype. The common A503V variant reduces P450c17 activity to ~60% of wild-type. Q153R causes ABS and has ~30% WT activity with P450c17 but 144% with CYP1A2 and 284% with CYP2C19, demonstrating substrate-specific activity differences. A287P and R457H dramatically reduce CYP3A4-mediated drug metabolism.","method":"In vitro enzyme activity assays with purified recombinant POR variants, multiple substrate assays (cytochrome c, P450c17, CYP1A2, CYP2C19, CYP3A4)","journal":"Molecular and cellular endocrinology","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic in vitro reconstitution of ~40 variants with multiple P450 substrates; mutagenesis plus functional assays in single rigorous study","pmids":["21070833"],"is_preprint":false},{"year":2012,"finding":"Neutron reflectometry of POR in nanodiscs revealed two distinct conformational states: a compact form (44 Å thick) and an extended form (79 Å thick). Upon complete reduction by NADPH, the equilibrium shifts toward the compact form, protecting the reduced FMN cofactor from non-specific electron transfer.","method":"Neutron reflectometry, nanodisc reconstitution, NADPH reduction","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — structural method (neutron reflectometry) with functional validation (NADPH-dependent conformational shift), single lab study","pmids":["22891242"],"is_preprint":false},{"year":2019,"finding":"Crystal structure of a CYPOR-HMOX1 fusion protein at 3.25 Å resolution revealed that NADP+ binding regulates conformational change in the FAD-binding domain of CYPOR, causing the FMN-binding domain to approach heme-bound HMOX1 and enhance electron-transfer efficiency from FMN to heme.","method":"X-ray crystallography (3.25 Å), structural comparison of NADP+-bound vs. NADP+-free forms","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure with functional mechanistic interpretation; single lab but direct structural evidence","pmids":["30883732"],"is_preprint":false},{"year":2020,"finding":"The novel POR R550W mutation causes near-complete loss of CYP19A1 (aromatase) activity, >95% loss of CYP17A1 and CYP21A2 activities, and significant loss of CYP2C9, CYP2C19, and CYP3A4 activities. R550W-POR showed 41% of WT cytochrome c reduction and 7.7% MTT reduction activity; reduced NADPH binding was also confirmed.","method":"Recombinant protein expression, cytochrome c reduction assay, MTT reduction, multiple P450 activity assays, NADPH binding measurement","journal":"The Journal of clinical endocrinology and metabolism","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with multiple P450 substrates and binding assay; single lab with multiple orthogonal methods","pmids":["32060549"],"is_preprint":false},{"year":2006,"finding":"POR knockout mice (Por-/-) exhibit early embryonic lethality (E9.5) associated with elevated and ectopic retinoic acid (RA) signaling. Compound Por-/-; Raldh2+/- mutants (reduced RA synthesis) survived to E13.5, rescuing brain patterning and vascular defects. Limb and caudal defects in these compound mutants phenocopied Cyp26a1-/- and Cyp26b1-/- mutants, demonstrating that POR function is required for CYP26-mediated RA metabolism during embryogenesis.","method":"Mouse knockout genetics, RA-reporter lacZ transgene, genetic epistasis (compound mutants with Raldh2 haploinsufficiency), serum-free embryo culture","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — epistasis by compound mutants with two independent rescue strategies; phenotype-genotype linked to CYP26 RA-metabolizing activity","pmids":["17126317"],"is_preprint":false},{"year":2013,"finding":"Zinc finger nuclease knockout of POR in HCT116 and SiHa tumor cell lines demonstrated that POR is required for hypoxia-activated prodrug (HAP) activation of the 5-nitroquinoline SN24349, but POR knockout had little or no effect on activation of most other HAPs including TH-302, PR-104A, and SN30000, indicating differential POR-dependence among one-electron reductase substrates.","method":"Zinc finger nuclease gene knockout, proteotypic peptide mass spectrometry quantitation, antiproliferative assay, reductive metabolism assay, clonogenic cell killing","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — functional null KO confirmed by mass spectrometry; multiple substrates tested; two cell line backgrounds; multiple orthogonal readouts","pmids":["24196959"],"is_preprint":false},{"year":2011,"finding":"siRNA-mediated knockdown of POR in McArdle-RH7777 rat hepatoma cells replicates hepatic lipidosis (triglyceride accumulation in lipid droplets) seen in hepatic POR-null mice. CYP51A1 suppression did not cause lipid accumulation, ruling out loss of cholesterol synthesis as the cause. Chenodeoxycholate addition repressed lipid accumulation, suggesting loss of bile acid synthesis and FXR signaling leads to triglyceride accumulation.","method":"siRNA knockdown, immunofluorescence lipid droplet staining, triglyceride quantification, pharmacological rescue with chenodeoxycholate","journal":"Drug metabolism and disposition","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO/KD with defined cellular phenotype and pharmacological rescue; single lab, two orthogonal approaches","pmids":["21368239"],"is_preprint":false},{"year":2011,"finding":"Knockdown of CYPOR (POR) in osteoblast cell lines decreased expression of Connexin 43 (Cx43) via transcriptional repression, and reduced gap junction intercellular communication (GJIC) and hemichannel activity. Primary osteoblasts from bone-specific Por knockdown mice confirmed decreased Cx43 expression.","method":"RNAi knockdown in osteoblast cell lines, promoter luciferase assay, GJIC functional assay, primary osteoblasts from conditional KO mice","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KD with defined cellular phenotype and transcriptional mechanism; confirmed in primary cells from KO mice; single lab","pmids":["21726529"],"is_preprint":false},{"year":2001,"finding":"Proper membrane association of POR with etioplast inner membranes (prolamellar bodies and prothylakoids) requires NADPH and hydrolysable ATP but not the transit peptide. A mutation in the nucleotide-binding site (ALA06) abolished NADPH-dependent membrane binding, and a substrate-binding site mutation (ALA24) reduced binding, demonstrating that cofactor interaction is essential for membrane association.","method":"In vitro-expressed radiolabelled POR, membrane binding assay, site-directed mutagenesis, thermolysin/NaOH/carbonate protection assays","journal":"The Plant journal","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with mutagenesis; single lab; plant ortholog","pmids":["11532175"],"is_preprint":false},{"year":2016,"finding":"Site-directed mutagenesis of multiple active site residues in POR (predicted to interact with NADPH or protochlorophyllide based on homology modeling) profoundly affected photochemistry, identifying residues critical for stabilizing the excited state required for light-driven catalysis.","method":"Active-site mutagenesis, static and time-resolved spectroscopy, homology modeling","journal":"Journal of photochemistry and photobiology. B, Biology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — mutagenesis with functional spectroscopic readout; single lab; no crystal structure to validate homology model","pmids":["27285815"],"is_preprint":false},{"year":2005,"finding":"The import of PORA precursor into plastids requires the GTP-binding protein Toc33 (but not Toc34). Plastids from ppi1 (Toc33-null) Arabidopsis mutants failed to import pPORA in darkness but imported pPORB, pSSU, and pFd normally, demonstrating a Toc33-specific import pathway for pPORA.","method":"Import assay into isolated plastids, genetic mutant (ppi1/Toc33-null), cross-linking, radiolabeled precursor proteins","journal":"The Plant journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct import assay with genetic mutant and orthogonal crosslinking; specific for PORA vs PORB discrimination; plant ortholog","pmids":["15773849"],"is_preprint":false},{"year":2023,"finding":"Ferrochelatase 2 (FC2) physically interacts with POR and stabilizes it; disruption of FC2-POR interaction attenuates suppression of ALA synthesis and leads to accumulation of photoreactive protochlorophyllide. FC2 interacts with both POR and the FLU regulator, promoting feedback suppression of glutamyl-tRNA reductase.","method":"Biochemical interaction assays, Arabidopsis mutant and complementation lines, co-immunoprecipitation-type analysis","journal":"The New phytologist","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical interaction with functional consequence in plant mutants; single lab; plant ortholog","pmids":["37161708"],"is_preprint":false},{"year":2023,"finding":"POR variants R268W and L577P (identified from gnomAD) expressed as recombinant proteins showed 35–85% decreased enzymatic activity with model substrates and reduced support for CYP3A4, CYP2C9, and CYP2C19 activities when reconstituted in liposomes.","method":"Recombinant protein expression in bacteria, enzyme kinetic assays, P450 reconstitution in liposomes","journal":"Biomolecules","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro reconstitution with mutagenesis; single lab; two variants tested","pmids":["38136599"],"is_preprint":false}],"current_model":"POR (NADPH-cytochrome P450 oxidoreductase) is a microsomal flavoprotein (containing FAD and FMN) that transfers electrons from NADPH to all microsomal cytochrome P450 enzymes (including steroidogenic CYP17A1, CYP21A2, CYP19A1, and drug-metabolizing CYP3A4, CYP2C9, CYP2C19, CYP1A2) as well as to heme oxygenase; NADP+ binding drives a conformational shift from an extended to a compact state that positions the FMN domain toward redox partners, and POR also catalyzes direct one-electron transfer from NAD(P)H to oxygen generating H2O2, which drives iron-dependent lipid peroxidation of polyunsaturated membrane phospholipids to execute ferroptosis; loss-of-function mutations in the FAD- or NADPH-binding domains impair steroidogenesis (causing P450 oxidoreductase deficiency/Antley-Bixler syndrome), disrupt retinoic acid homeostasis during embryogenesis through reduced CYP26 activity, and in liver lead to triglyceride accumulation through loss of bile acid synthesis."},"narrative":{"mechanistic_narrative":"POR (NADPH-cytochrome P450 oxidoreductase) is a microsomal flavoprotein that serves as the obligate electron donor for the cytochrome P450 system, shuttling reducing equivalents from NADPH to all microsomal P450 enzymes [PMID:2501655, PMID:21070833]. The recombinant human protein reduces cytochrome c and, when co-expressed, stimulates P450-mediated drug oxidation, establishing its function as a diffusible reductase partner [PMID:2501655]. Electron transfer is governed by a cofactor-driven conformational cycle: complete reduction by NADPH shifts the enzyme from an extended toward a compact form that sequesters the reduced FMN [PMID:22891242], and NADP+ binding to the FAD-binding domain drives the FMN-binding domain toward the heme of a redox partner to enhance electron transfer, as captured in a CYPOR-heme oxygenase fusion structure [PMID:30883732]. POR supplies electrons across a broad substrate range, supporting steroidogenic P450s (CYP17A1/P450c17, CYP21A2, CYP19A1/aromatase) and drug-metabolizing enzymes (CYP3A4, CYP2C9, CYP2C19, CYP1A2) with substrate-specific efficiencies, such that individual variants can impair some activities while sparing or even enhancing others [PMID:21070833, PMID:32060549]. Loss-of-function mutations in the FAD- or NADPH-binding domains cause P450 oxidoreductase deficiency/Antley-Bixler syndrome through disrupted steroidogenesis [PMID:15264278, PMID:32060549]. Beyond its P450-coupled role, POR acts as a one-electron reductase that transfers electrons from NADPH to oxygen to generate hydrogen peroxide, which through iron-dependent chemistry peroxidizes polyunsaturated membrane phospholipids to execute ferroptosis — an intrinsic enzymatic capacity reconstituted with purified POR in protein-free liposomes [PMID:33321093, PMID:33718888]. In vivo, POR is required for CYP26-mediated retinoic acid metabolism during embryogenesis, with knockout causing embryonic lethality from ectopic retinoic acid signaling [PMID:17126317], and hepatic POR loss produces triglyceride accumulation attributable to loss of bile acid synthesis [PMID:21368239].","teleology":[{"year":1989,"claim":"Established that the cloned human POR gene encodes an enzymatically active reductase that functionally couples to cytochrome P450, defining its core role as a P450 electron donor.","evidence":"Vaccinia virus heterologous expression, cytochrome c reduction, and co-infection P450 enzymatic assays, with chromosomal mapping to 7p15-q35","pmids":["2501655"],"confidence":"High","gaps":["Did not resolve the structural basis of electron transfer","Tested with limited P450 substrates"]},{"year":2004,"claim":"Linked POR loss-of-function directly to human disease, showing it is the obligate electron donor for multiple steroidogenic P450s.","evidence":"Patient DNA sequencing identifying compound heterozygous FAD-domain mutations (e.g. R454H) in Antley-Bixler syndrome with steroidogenesis defects","pmids":["15264278"],"confidence":"Medium","gaps":["Mechanism inferred from domain annotation without in vitro reconstitution","Single study"]},{"year":2010,"claim":"Demonstrated that POR variants confer substrate-specific changes in P450 support, explaining why cytochrome c assays poorly predict clinical phenotype.","evidence":"In vitro reconstitution of ~40 recombinant POR variants assayed against cytochrome c, P450c17, CYP1A2, CYP2C19 and CYP3A4","pmids":["21070833"],"confidence":"High","gaps":["Did not map activity differences to defined structural states","In vitro activities not validated against in vivo steroid output for all variants"]},{"year":2012,"claim":"Resolved how cofactor reduction controls POR conformation, defining a structural mechanism that protects the reduced FMN.","evidence":"Neutron reflectometry of nanodisc-reconstituted POR before and after NADPH reduction, revealing compact and extended states","pmids":["22891242"],"confidence":"High","gaps":["Single lab method","Did not capture the partner-bound state"]},{"year":2019,"claim":"Provided atomic-level evidence that NADP+ binding repositions the FMN domain toward the redox partner to drive electron transfer.","evidence":"X-ray crystallography (3.25 A) of a CYPOR-HMOX1 fusion comparing NADP+-bound and free states","pmids":["30883732"],"confidence":"High","gaps":["Captured with heme oxygenase rather than a P450 partner","Single structure of a fusion construct"]},{"year":2006,"claim":"Established an in vivo developmental requirement for POR in retinoic acid homeostasis via CYP26 enzymes.","evidence":"Por knockout mouse genetics with RA-reporter readout and genetic epistasis using Raldh2 haploinsufficiency and phenocopy of Cyp26 mutants","pmids":["17126317"],"confidence":"High","gaps":["Embryonic lethality limits analysis of later roles","Does not isolate CYP26 from other P450 contributions to the full phenotype"]},{"year":2011,"claim":"Connected hepatic POR loss to triglyceride accumulation through loss of bile acid synthesis rather than cholesterol synthesis.","evidence":"siRNA knockdown in rat hepatoma cells, lipid droplet staining, triglyceride quantification, and chenodeoxycholate rescue, with CYP51A1 control","pmids":["21368239"],"confidence":"Medium","gaps":["FXR-signaling link inferred from pharmacological rescue","Single lab in vitro system"]},{"year":2011,"claim":"Identified a P450-independent role for POR in regulating osteoblast gap junction communication.","evidence":"RNAi knockdown in osteoblast lines with Cx43 promoter luciferase, GJIC assay, and primary osteoblasts from bone-specific KO mice","pmids":["21726529"],"confidence":"Medium","gaps":["Transcriptional mechanism linking POR to Cx43 not defined","Single lab"]},{"year":2013,"claim":"Established POR as a determinant of hypoxia-activated prodrug activation with substrate selectivity among one-electron reductase substrates.","evidence":"Zinc finger nuclease knockout in HCT116 and SiHa cells with mass-spectrometry-confirmed null status and multiple prodrug activation readouts","pmids":["24196959"],"confidence":"High","gaps":["Does not identify the reductases responsible for POR-independent prodrugs","Two tumor cell backgrounds only"]},{"year":2020,"claim":"Defined POR as a driver of ferroptosis through NADPH-dependent generation of hydrogen peroxide that fuels lipid peroxidation.","evidence":"CRISPR knockout, H2O2 measurement, lipid peroxidation assays, and a ConA-induced mouse liver knockdown model","pmids":["33321093"],"confidence":"High","gaps":["Relative contribution of POR versus other oxidoreductases to ferroptosis in different tissues unresolved"]},{"year":2021,"claim":"Confirmed that POR has intrinsic enzymatic capacity to peroxidize PUFA phospholipids independent of cellular context.","evidence":"Cell-free reconstitution with purified POR (and CYB5R1) in protein-free liposomes using Tb3+ release and electron microscopy","pmids":["33718888"],"confidence":"High","gaps":["Does not quantify in vivo contribution relative to enzymatic context","Protocol-format report"]},{"year":2020,"claim":"Extended the genotype-phenotype map by characterizing a variant (R550W) that ablates aromatase and most steroidogenic and drug-metabolizing P450 support.","evidence":"Recombinant protein with cytochrome c and MTT reduction, multiple P450 activity assays, and NADPH binding measurement","pmids":["32060549"],"confidence":"High","gaps":["Single variant","In vitro activities not linked to clinical outcome in this study"]},{"year":2023,"claim":"Characterized additional population variants confirming reduced P450 support, broadening the spectrum of functionally impaired POR alleles.","evidence":"Recombinant expression of gnomAD-derived R268W and L577P with enzyme kinetics and liposome P450 reconstitution","pmids":["38136599"],"confidence":"Medium","gaps":["Two variants only","Single lab, no in vivo validation"]},{"year":null,"claim":"It remains unresolved how POR's conformational cycle, partner selectivity, and one-electron oxygen-reductase activity are coordinated to partition between productive P450 catalysis and ferroptotic lipid peroxidation in specific tissues.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structure of POR bound to a steroidogenic P450 partner","Tissue-specific control of P450 coupling versus H2O2 generation undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[0,1,2,4,7]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[2,4,6,7]},{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[0,2,5]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[2,4]}],"pathway":[{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[0,1]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[3,4,10]},{"term_id":"R-HSA-9748784","term_label":"Drug ADME","supporting_discovery_ids":[4,9,16]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[8]}],"complexes":[],"partners":["HMOX1","CYP17A1","CYP21A2","CYP19A1","CYP3A4","CYP2C9","CYP2C19"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P16435","full_name":"NADPH--cytochrome P450 reductase","aliases":[],"length_aa":677,"mass_kda":76.7,"function":"This enzyme is required for electron transfer from NADP to cytochrome P450 in microsomes. It can also provide electron transfer to heme oxygenase and cytochrome B5","subcellular_location":"Endoplasmic reticulum membrane","url":"https://www.uniprot.org/uniprotkb/P16435/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/POR","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"DAD1","stoichiometry":10.0},{"gene":"RPN2","stoichiometry":10.0},{"gene":"SEC61B","stoichiometry":10.0},{"gene":"STT3B","stoichiometry":10.0},{"gene":"DDOST","stoichiometry":4.0},{"gene":"RPN1","stoichiometry":4.0},{"gene":"BCAP31","stoichiometry":0.2},{"gene":"CANX","stoichiometry":0.2},{"gene":"CLASP2","stoichiometry":0.2},{"gene":"EMC4","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/POR","total_profiled":1310},"omim":[{"mim_id":"618267","title":"EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 3; EV3","url":"https://www.omim.org/entry/618267"},{"mim_id":"615341","title":"CYTOCHROME P450, FAMILY 4, SUBFAMILY A, POLYPEPTIDE 22; CYP4A22","url":"https://www.omim.org/entry/615341"},{"mim_id":"614416","title":"RADIOHUMERAL FUSIONS WITH OTHER SKELETAL AND CRANIOFACIAL ANOMALIES; RHFCA","url":"https://www.omim.org/entry/614416"},{"mim_id":"614279","title":"46,XY SEX REVERSAL 8; SRXY8","url":"https://www.omim.org/entry/614279"},{"mim_id":"613571","title":"DISORDERED STEROIDOGENESIS DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY","url":"https://www.omim.org/entry/613571"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Vesicles","reliability":"Supported"},{"location":"Nucleoplasm","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"liver","ntpm":292.8}],"url":"https://www.proteinatlas.org/search/POR"},"hgnc":{"alias_symbol":["CYPOR","FLJ26468"],"prev_symbol":[]},"alphafold":{"accession":"P16435","domains":[{"cath_id":"3.40.50.360","chopping":"70-232","consensus_level":"high","plddt":94.7483,"start":70,"end":232},{"cath_id":"2.40.30.10","chopping":"272-324_454-517","consensus_level":"medium","plddt":94.8741,"start":272,"end":517},{"cath_id":"1.20.990.10","chopping":"326-453","consensus_level":"medium","plddt":95.281,"start":326,"end":453},{"cath_id":"3.40.50.80","chopping":"529-676","consensus_level":"high","plddt":97.1575,"start":529,"end":676}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P16435","model_url":"https://alphafold.ebi.ac.uk/files/AF-P16435-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P16435-F1-predicted_aligned_error_v6.png","plddt_mean":91.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=POR","jax_strain_url":"https://www.jax.org/strain/search?query=POR"},"sequence":{"accession":"P16435","fasta_url":"https://rest.uniprot.org/uniprotkb/P16435.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P16435/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P16435"}},"corpus_meta":[{"pmid":"33321093","id":"PMC_33321093","title":"Membrane Damage during Ferroptosis Is Caused by Oxidation of Phospholipids Catalyzed by the Oxidoreductases POR and CYB5R1.","date":"2020","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/33321093","citation_count":507,"is_preprint":false},{"pmid":"23123910","id":"PMC_23123910","title":"Gliding motility and Por secretion system genes are widespread among members of the phylum bacteroidetes.","date":"2012","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/23123910","citation_count":237,"is_preprint":false},{"pmid":"1705642","id":"PMC_1705642","title":"Point mutation in meningococcal por A gene associated with increased endemic disease.","date":"1991","source":"Lancet (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/1705642","citation_count":167,"is_preprint":false},{"pmid":"21731719","id":"PMC_21731719","title":"Por secretion system-dependent secretion and glycosylation of Porphyromonas gingivalis hemin-binding protein 35.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21731719","citation_count":133,"is_preprint":false},{"pmid":"23075153","id":"PMC_23075153","title":"Identification of Porphyromonas gingivalis proteins secreted by the Por secretion system.","date":"2012","source":"FEMS microbiology letters","url":"https://pubmed.ncbi.nlm.nih.gov/23075153","citation_count":121,"is_preprint":false},{"pmid":"24658827","id":"PMC_24658827","title":"The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients.","date":"2014","source":"European journal of clinical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24658827","citation_count":108,"is_preprint":false},{"pmid":"9351249","id":"PMC_9351249","title":"Overexpression of light-dependent PORA or PORB in plants depleted of endogenous POR by far-red light enhances seedling survival in white light and protects against photooxidative damage.","date":"1997","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9351249","citation_count":91,"is_preprint":false},{"pmid":"8313365","id":"PMC_8313365","title":"Quantification of CYP2B7, CYP4B1, and CYPOR messenger RNAs in normal human lung and lung tumors.","date":"1994","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/8313365","citation_count":90,"is_preprint":false},{"pmid":"15264278","id":"PMC_15264278","title":"Compound heterozygous mutations of cytochrome P450 oxidoreductase gene (POR) in two patients with Antley-Bixler syndrome.","date":"2004","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/15264278","citation_count":84,"is_preprint":false},{"pmid":"24061445","id":"PMC_24061445","title":"Impact of POR*28 on the pharmacokinetics of tacrolimus and cyclosporine A in renal transplant patients.","date":"2014","source":"Therapeutic drug monitoring","url":"https://pubmed.ncbi.nlm.nih.gov/24061445","citation_count":80,"is_preprint":false},{"pmid":"8624514","id":"PMC_8624514","title":"Distinct roles for light-dependent NADPH:protochlorophyllide oxidoreductases (POR) A and B during greening in higher plants.","date":"1996","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8624514","citation_count":77,"is_preprint":false},{"pmid":"2501655","id":"PMC_2501655","title":"Human NADPH-P450 oxidoreductase: complementary DNA cloning, sequence and vaccinia virus-mediated expression and localization of the CYPOR gene to chromosome 7.","date":"1989","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/2501655","citation_count":73,"is_preprint":false},{"pmid":"8149379","id":"PMC_8149379","title":"Recognition of synthetic O-methyl, epimeric, and amino analogues of the acceptor alpha-L-Fuc p-(1-->2)-beta-D-Gal p-OR by the blood-group A and B gene-specified glycosyltransferases.","date":"1994","source":"Carbohydrate research","url":"https://pubmed.ncbi.nlm.nih.gov/8149379","citation_count":72,"is_preprint":false},{"pmid":"21070833","id":"PMC_21070833","title":"Consequences of POR mutations and polymorphisms.","date":"2010","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21070833","citation_count":68,"is_preprint":false},{"pmid":"1323620","id":"PMC_1323620","title":"Gonococcal porin vaccine evaluation: comparison of Por proteosomes, liposomes, and blebs isolated from rmp deletion mutants.","date":"1992","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/1323620","citation_count":68,"is_preprint":false},{"pmid":"10482498","id":"PMC_10482498","title":"Genetic diversity and mosaicism at the por locus of Neisseria gonorrhoeae.","date":"1999","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/10482498","citation_count":61,"is_preprint":false},{"pmid":"17126317","id":"PMC_17126317","title":"Rescue of cytochrome P450 oxidoreductase (Por) mouse mutants reveals functions in vasculogenesis, brain and limb patterning linked to retinoic acid homeostasis.","date":"2006","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/17126317","citation_count":52,"is_preprint":false},{"pmid":"22891242","id":"PMC_22891242","title":"Monitoring shifts in the conformation equilibrium of the membrane protein cytochrome P450 reductase (POR) in nanodiscs.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22891242","citation_count":51,"is_preprint":false},{"pmid":"8252553","id":"PMC_8252553","title":"Recognition of synthetic deoxy and deoxyfluoro analogs of the acceptor alpha-L-Fuc p-(1-->2)-beta-D-Gal p-OR by the blood-group A and B gene-specified glycosyltransferases.","date":"1993","source":"Carbohydrate research","url":"https://pubmed.ncbi.nlm.nih.gov/8252553","citation_count":45,"is_preprint":false},{"pmid":"31173817","id":"PMC_31173817","title":"Activation of the p38/MAPK pathway regulates autophagy in response to the CYPOR-dependent oxidative stress induced by zearalenone in porcine intestinal epithelial cells.","date":"2019","source":"Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association","url":"https://pubmed.ncbi.nlm.nih.gov/31173817","citation_count":43,"is_preprint":false},{"pmid":"23966131","id":"PMC_23966131","title":"Spatial and stimulus-type tuning in the LEC, MEC, POR, PrC, CA1, and CA3 during spontaneous item recognition memory.","date":"2013","source":"Hippocampus","url":"https://pubmed.ncbi.nlm.nih.gov/23966131","citation_count":40,"is_preprint":false},{"pmid":"24433464","id":"PMC_24433464","title":"Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance.","date":"2014","source":"British journal of clinical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24433464","citation_count":40,"is_preprint":false},{"pmid":"26227094","id":"PMC_26227094","title":"The genetic polymorphisms of POR*28 and CYP3A5*3 significantly influence the pharmacokinetics of tacrolimus in Chinese renal transplant recipients.","date":"2015","source":"International journal of clinical pharmacology and therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/26227094","citation_count":39,"is_preprint":false},{"pmid":"15143477","id":"PMC_15143477","title":"Quinolone resistance-determining region mutations and por type of Neisseria gonorrhoeae isolates: resistance surveillance and typing by molecular methodologies.","date":"2004","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/15143477","citation_count":37,"is_preprint":false},{"pmid":"12401790","id":"PMC_12401790","title":"In vitro reconstitution of light-harvesting POR-protochlorophyllide complex with protochlorophyllides a and b.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12401790","citation_count":37,"is_preprint":false},{"pmid":"31096684","id":"PMC_31096684","title":"Impact of CYP3A5, POR, and CYP2C19 Polymorphisms on Trough Concentration to Dose Ratio of Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplantation.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31096684","citation_count":33,"is_preprint":false},{"pmid":"11101576","id":"PMC_11101576","title":"Comparison of sequencing of the por gene and typing of the opa gene for discrimination of Neisseria gonorrhoeae strains from sexual contacts.","date":"2000","source":"Journal of clinical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/11101576","citation_count":32,"is_preprint":false},{"pmid":"9578474","id":"PMC_9578474","title":"Chlorophyll alpha synthesis upon interruption and deletion of por coding for the light-dependent NADPH: protochlorophyllide oxidoreductase in a photosystem-I-less/chlL- strain of Synechocystis sp. PCC 6803.","date":"1998","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9578474","citation_count":32,"is_preprint":false},{"pmid":"19266521","id":"PMC_19266521","title":"Hydrogen-atom transfer in reactions of organic radicals with [Co(II)(por)]* (por = porphyrinato) and in subsequent addition of [Co(H)(por)] to olefins.","date":"2009","source":"Chemistry (Weinheim an der Bergstrasse, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/19266521","citation_count":31,"is_preprint":false},{"pmid":"12696000","id":"PMC_12696000","title":"Porin variation among clinical isolates of Neisseria gonorrhoeae over a 10-year period, as determined by Por variable region typing.","date":"2003","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/12696000","citation_count":28,"is_preprint":false},{"pmid":"28288674","id":"PMC_28288674","title":"Cytochrome P450 oxidoreductase deficiency caused by R457H mutation in POR gene in Chinese: case report and literature review.","date":"2017","source":"Journal of ovarian research","url":"https://pubmed.ncbi.nlm.nih.gov/28288674","citation_count":27,"is_preprint":false},{"pmid":"23974086","id":"PMC_23974086","title":"Effect of CYP3A4*22, POR*28, and PPARA rs4253728 on sirolimus in vitro metabolism and trough concentrations in kidney transplant recipients.","date":"2013","source":"Clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23974086","citation_count":27,"is_preprint":false},{"pmid":"28078486","id":"PMC_28078486","title":"Two NADPH: Protochlorophyllide Oxidoreductase (POR) Isoforms Play Distinct Roles in Environmental Adaptation in Rice.","date":"2017","source":"Rice (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/28078486","citation_count":27,"is_preprint":false},{"pmid":"15773849","id":"PMC_15773849","title":"A role of Toc33 in the protochlorophyllide-dependent plastid import pathway of NADPH:protochlorophyllide oxidoreductase (POR) A.","date":"2005","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15773849","citation_count":25,"is_preprint":false},{"pmid":"24464600","id":"PMC_24464600","title":"CYP2C9*2 allele increases risk for hypoglycemia in POR*1/*1 type 2 diabetic patients treated with sulfonylureas.","date":"2014","source":"Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association","url":"https://pubmed.ncbi.nlm.nih.gov/24464600","citation_count":24,"is_preprint":false},{"pmid":"12602886","id":"PMC_12602886","title":"POR hits the road: import and assembly of a plastid protein.","date":"2003","source":"Plant molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12602886","citation_count":22,"is_preprint":false},{"pmid":"28656666","id":"PMC_28656666","title":"Interaction between variants in the CYP2C9 and POR genes and the risk of sulfonylurea-induced hypoglycaemia: A GoDARTS Study.","date":"2017","source":"Diabetes, obesity & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/28656666","citation_count":22,"is_preprint":false},{"pmid":"24196959","id":"PMC_24196959","title":"Zinc finger nuclease knock-out of NADPH:cytochrome P450 oxidoreductase (POR) in human tumor cell lines demonstrates that hypoxia-activated prodrugs differ in POR dependence.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24196959","citation_count":20,"is_preprint":false},{"pmid":"21718029","id":"PMC_21718029","title":"Antitumor actinopyranones produced by Streptomyces albus POR-04-15-053 isolated from a marine sediment.","date":"2011","source":"Journal of natural products","url":"https://pubmed.ncbi.nlm.nih.gov/21718029","citation_count":20,"is_preprint":false},{"pmid":"10825311","id":"PMC_10825311","title":"Ornipressin (Por 8): An efficient alternative to counteract hypotension during combined general/epidural anesthesia.","date":"2000","source":"Anesthesia and analgesia","url":"https://pubmed.ncbi.nlm.nih.gov/10825311","citation_count":19,"is_preprint":false},{"pmid":"24448396","id":"PMC_24448396","title":"Variation in P450 oxidoreductase (POR) A503V and flavin-containing monooxygenase (FMO)-3 E158K is associated with minor alterations in nicotine metabolism, but does not alter cigarette consumption.","date":"2014","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/24448396","citation_count":18,"is_preprint":false},{"pmid":"11532175","id":"PMC_11532175","title":"Association of the NADPH:protochlorophyllide oxidoreductase (POR) with isolated etioplast inner membranes from wheat.","date":"2001","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11532175","citation_count":18,"is_preprint":false},{"pmid":"27285815","id":"PMC_27285815","title":"Multiple active site residues are important for photochemical efficiency in the light-activated enzyme protochlorophyllide oxidoreductase (POR).","date":"2016","source":"Journal of photochemistry and photobiology. B, Biology","url":"https://pubmed.ncbi.nlm.nih.gov/27285815","citation_count":18,"is_preprint":false},{"pmid":"32826979","id":"PMC_32826979","title":"Genetic control of CCL24, POR, and IL23R contributes to the pathogenesis of sarcoidosis.","date":"2020","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/32826979","citation_count":17,"is_preprint":false},{"pmid":"21368239","id":"PMC_21368239","title":"Suppression of cytochrome P450 reductase (POR) expression in hepatoma cells replicates the hepatic lipidosis observed in hepatic POR-null mice.","date":"2011","source":"Drug metabolism and disposition: the biological fate of chemicals","url":"https://pubmed.ncbi.nlm.nih.gov/21368239","citation_count":17,"is_preprint":false},{"pmid":"25521355","id":"PMC_25521355","title":"POR*28 SNP is associated with lipid response to atorvastatin in children and adolescents with familial hypercholesterolemia.","date":"2014","source":"Pharmacogenomics","url":"https://pubmed.ncbi.nlm.nih.gov/25521355","citation_count":17,"is_preprint":false},{"pmid":"9787456","id":"PMC_9787456","title":"Loblolly pine (Pinus taeda L.) contains multiple expressed genes encoding light-dependent NADPH:protochlorophyllide oxidoreductase (POR).","date":"1998","source":"Plant & cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9787456","citation_count":17,"is_preprint":false},{"pmid":"32060549","id":"PMC_32060549","title":"Molecular Basis of CYP19A1 Deficiency in a 46,XX Patient With R550W Mutation in POR: Expanding the PORD Phenotype.","date":"2020","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/32060549","citation_count":17,"is_preprint":false},{"pmid":"16274361","id":"PMC_16274361","title":"Spectroscopic and kinetic characterization of the light-dependent enzyme protochlorophyllide oxidoreductase (POR) using monovinyl and divinyl substrates.","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16274361","citation_count":16,"is_preprint":false},{"pmid":"36840768","id":"PMC_36840768","title":"MicroRNAs in POI, DOR and POR.","date":"2023","source":"Archives of gynecology and obstetrics","url":"https://pubmed.ncbi.nlm.nih.gov/36840768","citation_count":14,"is_preprint":false},{"pmid":"37036615","id":"PMC_37036615","title":"Zoledronic acid induces ferroptosis by upregulating POR in osteosarcoma.","date":"2023","source":"Medical oncology (Northwood, London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/37036615","citation_count":14,"is_preprint":false},{"pmid":"26293521","id":"PMC_26293521","title":"Interactions between CYP3A5*3 and POR*28 polymorphisms and lipid lowering response with atorvastatin.","date":"2015","source":"Clinical drug investigation","url":"https://pubmed.ncbi.nlm.nih.gov/26293521","citation_count":14,"is_preprint":false},{"pmid":"29135906","id":"PMC_29135906","title":"Effect of Age and Allele Variants of CYP3A5, CYP3A4, and POR Genes on the Pharmacokinetics of Cyclosporin A in Pediatric Renal Transplant Recipients From Serbia.","date":"2017","source":"Therapeutic drug monitoring","url":"https://pubmed.ncbi.nlm.nih.gov/29135906","citation_count":14,"is_preprint":false},{"pmid":"20726527","id":"PMC_20726527","title":"Unprecedented peroxidase-like activity of Rhodnius prolixus nitrophorin 2: identification of the [FeIV=O Por•]+ and [FeIV=O Por](Tyr38•) intermediates and their role(s) in substrate oxidation.","date":"2010","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20726527","citation_count":14,"is_preprint":false},{"pmid":"26670660","id":"PMC_26670660","title":"Prenatal Diagnosis of Antley-Bixler Syndrome and POR Deficiency.","date":"2015","source":"The American journal of case reports","url":"https://pubmed.ncbi.nlm.nih.gov/26670660","citation_count":14,"is_preprint":false},{"pmid":"32725309","id":"PMC_32725309","title":"Clinical and genetic analysis of cytochrome P450 oxidoreductase (POR) deficiency in a female and the analysis of a novel POR intron mutation causing alternative mRNA splicing : Overall analysis of a female with POR deficiency.","date":"2020","source":"Journal of assisted reproduction and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32725309","citation_count":13,"is_preprint":false},{"pmid":"17459331","id":"PMC_17459331","title":"Molecular rearrangement in POR macrodomains as a reason for the blue shift of chlorophyllide fluorescence observed after phototransformation.","date":"2007","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/17459331","citation_count":13,"is_preprint":false},{"pmid":"15814961","id":"PMC_15814961","title":"por Variable-region typing by DNA probe hybridization is broadly applicable to epidemiologic studies of Neisseria gonorrhoeae.","date":"2005","source":"Journal of clinical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/15814961","citation_count":13,"is_preprint":false},{"pmid":"16307122","id":"PMC_16307122","title":"Kinetic characterisation of the light-driven protochlorophyllide oxidoreductase (POR) from Thermosynechococcus elongatus.","date":"2005","source":"Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology","url":"https://pubmed.ncbi.nlm.nih.gov/16307122","citation_count":13,"is_preprint":false},{"pmid":"8187102","id":"PMC_8187102","title":"Recognition of synthetic analogues of the acceptor, beta-D-Gal p-OR, by the blood-group H gene-specified glycosyltransferase.","date":"1994","source":"Carbohydrate research","url":"https://pubmed.ncbi.nlm.nih.gov/8187102","citation_count":13,"is_preprint":false},{"pmid":"30883732","id":"PMC_30883732","title":"Crystal structure of a NADPH-cytochrome P450 oxidoreductase (CYPOR) and heme oxygenase 1 fusion protein implies a conformational change in CYPOR upon NADPH/NADP+ binding.","date":"2019","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/30883732","citation_count":11,"is_preprint":false},{"pmid":"19290868","id":"PMC_19290868","title":"Ultrafast catalytic processes and conformational changes in the light-driven enzyme protochlorophyllide oxidoreductase (POR).","date":"2009","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/19290868","citation_count":11,"is_preprint":false},{"pmid":"31035011","id":"PMC_31035011","title":"Sulforaphane alleviates cadmium-induced toxicity in human mesenchymal stem cells through POR and TNFSF10 genes expression.","date":"2019","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/31035011","citation_count":11,"is_preprint":false},{"pmid":"16858667","id":"PMC_16858667","title":"Molecular cloning and expression of progesterone 5beta-reductase (5beta-POR) from Isoplexis canariensis.","date":"2006","source":"Planta medica","url":"https://pubmed.ncbi.nlm.nih.gov/16858667","citation_count":11,"is_preprint":false},{"pmid":"11532173","id":"PMC_11532173","title":"Elimination of POR expression correlates with red leaf formation in Amaranthus tricolor.","date":"2001","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11532173","citation_count":11,"is_preprint":false},{"pmid":"32225074","id":"PMC_32225074","title":"Influence of POR*28 Polymorphisms on CYP3A5*3-Associated Variations in Tacrolimus Blood Levels at an Early Stage after Liver Transplantation.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32225074","citation_count":11,"is_preprint":false},{"pmid":"33734692","id":"PMC_33734692","title":"A Porphyrin-Involved Benzene-1,3,5-Tricarboxamide Dendrimer (Por-BTA) as a Multifunctional Interface Material for Efficient and Stable Perovskite Solar Cells.","date":"2021","source":"ACS applied materials & interfaces","url":"https://pubmed.ncbi.nlm.nih.gov/33734692","citation_count":11,"is_preprint":false},{"pmid":"35842891","id":"PMC_35842891","title":"Congenital adrenal hyperplasia, disorders of sex development, and infertility in patients with POR gene pathogenic variants: a systematic review of the literature.","date":"2022","source":"Journal of endocrinological investigation","url":"https://pubmed.ncbi.nlm.nih.gov/35842891","citation_count":10,"is_preprint":false},{"pmid":"27439448","id":"PMC_27439448","title":"The P450 oxidoreductase (POR) rs2868177 and cytochrome P450 (CYP) 2B6*6 polymorphisms contribute to the interindividual variability in human CYP2B6 activity.","date":"2016","source":"European journal of clinical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27439448","citation_count":10,"is_preprint":false},{"pmid":"26969897","id":"PMC_26969897","title":"Compound heterozygosity of a paternal submicroscopic deletion and a maternal missense mutation in POR gene: Antley-bixler syndrome phenotype in three sibling fetuses.","date":"2016","source":"Birth defects research. Part A, Clinical and molecular teratology","url":"https://pubmed.ncbi.nlm.nih.gov/26969897","citation_count":10,"is_preprint":false},{"pmid":"37161708","id":"PMC_37161708","title":"FC2 stabilizes POR and suppresses ALA formation in the tetrapyrrole biosynthesis pathway.","date":"2023","source":"The New phytologist","url":"https://pubmed.ncbi.nlm.nih.gov/37161708","citation_count":9,"is_preprint":false},{"pmid":"38136599","id":"PMC_38136599","title":"Exploring Novel Variants of the Cytochrome P450 Reductase Gene (POR) from the Genome Aggregation Database by Integrating Bioinformatic Tools and Functional Assays.","date":"2023","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/38136599","citation_count":9,"is_preprint":false},{"pmid":"26669712","id":"PMC_26669712","title":"P450 (Cytochrome) Oxidoreductase Gene (POR) Common Variant (POR*28) Significantly Alters CYP2C9 Activity in Swedish, But Not in Korean Healthy Subjects.","date":"2015","source":"Omics : a journal of integrative biology","url":"https://pubmed.ncbi.nlm.nih.gov/26669712","citation_count":9,"is_preprint":false},{"pmid":"23624273","id":"PMC_23624273","title":"CYP1A and POR gene mediated mitochondrial membrane damage induced by carbon nanoparticle in human mesenchymal stem cells.","date":"2013","source":"Environmental toxicology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/23624273","citation_count":9,"is_preprint":false},{"pmid":"32851239","id":"PMC_32851239","title":"Compound heterozygous variants in POR gene identified by whole-exome sequencing in a Chinese pedigree with cytochrome P450 oxidoreductase deficiency.","date":"2018","source":"Pediatric investigation","url":"https://pubmed.ncbi.nlm.nih.gov/32851239","citation_count":9,"is_preprint":false},{"pmid":"21726529","id":"PMC_21726529","title":"Regulation of gap junction function and Connexin 43 expression by cytochrome P450 oxidoreductase (CYPOR).","date":"2011","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/21726529","citation_count":8,"is_preprint":false},{"pmid":"34654938","id":"PMC_34654938","title":"Generation of Caco-2 cells stably expressing CYP3A4·POR·UGT1A1 and CYP3A4·POR·UGT1A1*6 using a PITCh system.","date":"2021","source":"Archives of toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/34654938","citation_count":8,"is_preprint":false},{"pmid":"33718888","id":"PMC_33718888","title":"Assessing POR and CYB5R1 oxidoreductase-mediated oxidative rupture of PUFA in liposomes.","date":"2021","source":"STAR protocols","url":"https://pubmed.ncbi.nlm.nih.gov/33718888","citation_count":8,"is_preprint":false},{"pmid":"33123976","id":"PMC_33123976","title":"Cytochrome P450 oxidoreductase deficiency caused by a novel mutation in the POR gene in two siblings: case report and literature review.","date":"2020","source":"Hormones (Athens, Greece)","url":"https://pubmed.ncbi.nlm.nih.gov/33123976","citation_count":8,"is_preprint":false},{"pmid":"39316946","id":"PMC_39316946","title":"Z-Ligustilide restricts rabies virus replication by inducing ferroptosis through the ACSL4-LPCAT3-POR pathway.","date":"2024","source":"Veterinary microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/39316946","citation_count":8,"is_preprint":false},{"pmid":"33974505","id":"PMC_33974505","title":"Association of polymorphism of CYP3A4, ABCB1, ABCC2, ABCG2, NFKB1, POR, and PXR with the concentration of cyclosporin A in allogeneic haematopoietic stem cell transplantation recipients.","date":"2021","source":"Xenobiotica; the fate of foreign compounds in biological systems","url":"https://pubmed.ncbi.nlm.nih.gov/33974505","citation_count":8,"is_preprint":false},{"pmid":"27376429","id":"PMC_27376429","title":"Delayed diagnosis of disorder of sex development (DSD) due to P450 oxidoreductase (POR) deficiency.","date":"2016","source":"Hormones (Athens, Greece)","url":"https://pubmed.ncbi.nlm.nih.gov/27376429","citation_count":8,"is_preprint":false},{"pmid":"16228553","id":"PMC_16228553","title":"POR structural domains important for the enzyme activity in R. capsulatus complementation system.","date":"2002","source":"Photosynthesis research","url":"https://pubmed.ncbi.nlm.nih.gov/16228553","citation_count":8,"is_preprint":false},{"pmid":"23325047","id":"PMC_23325047","title":"Modeling of Anopheles minimus Mosquito NADPH-cytochrome P450 oxidoreductase (CYPOR) and mutagenesis analysis.","date":"2013","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/23325047","citation_count":7,"is_preprint":false},{"pmid":"37173831","id":"PMC_37173831","title":"Computational identification and analysis of deleterious non-synonymous single nucleotide polymorphisms (nsSNPs) in the human POR gene: a structural and functional impact.","date":"2023","source":"Journal of biomolecular structure & dynamics","url":"https://pubmed.ncbi.nlm.nih.gov/37173831","citation_count":7,"is_preprint":false},{"pmid":"32704063","id":"PMC_32704063","title":"Epigenetic alterations in cytochrome P450 oxidoreductase (Por) in sperm of rats exposed to tetrahydrocannabinol (THC).","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32704063","citation_count":7,"is_preprint":false},{"pmid":"26854662","id":"PMC_26854662","title":"Evolution of NADPH-cytochrome P450 oxidoreductases (POR) in Apiales - POR 1 is missing.","date":"2016","source":"Molecular phylogenetics and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/26854662","citation_count":7,"is_preprint":false},{"pmid":"18839334","id":"PMC_18839334","title":"Expression and sequence variation of the cucumber Por gene in the synthesized allotetraploid Cucumis x hytivus.","date":"2008","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/18839334","citation_count":6,"is_preprint":false},{"pmid":"18275186","id":"PMC_18275186","title":"Theoretical study of specific hydrogen-bonding effects on the bridging P-OR bond strength of phosphate monoester dianions.","date":"2008","source":"The journal of physical chemistry. B","url":"https://pubmed.ncbi.nlm.nih.gov/18275186","citation_count":6,"is_preprint":false},{"pmid":"36321415","id":"PMC_36321415","title":"POR overexpression induces tamoxifen-resistance in breast cancer through the STAT1/c-Myc pathway.","date":"2022","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/36321415","citation_count":5,"is_preprint":false},{"pmid":"35578867","id":"PMC_35578867","title":"Impact of POR*28 Variant on Tacrolimus Pharmacokinetics in Kidney Transplant Patients with Different CYP3A5 Genotypes.","date":"2022","source":"Current drug metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/35578867","citation_count":5,"is_preprint":false},{"pmid":"24419666","id":"PMC_24419666","title":"\"Pig in a poke (gato por liebre)\": the \"mota\" (Calophysus macropterus) fishery, molecular evidence of commercialization in Colombia and toxicological analyses.","date":"2014","source":"EcoHealth","url":"https://pubmed.ncbi.nlm.nih.gov/24419666","citation_count":5,"is_preprint":false},{"pmid":"31182881","id":"PMC_31182881","title":"[Supervivencia en cáncer de mama por subtipo mediante inmunohistoquímica: Un estudio retrospectivo].","date":"2019","source":"Gaceta medica de Mexico","url":"https://pubmed.ncbi.nlm.nih.gov/31182881","citation_count":4,"is_preprint":false},{"pmid":"30360443","id":"PMC_30360443","title":"Genetic Polymorphisms and In Silico Mutagenesis Analyses of CYP2C9, CYP2D6, and CYPOR Genes in the Pakistani Population.","date":"2018","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/30360443","citation_count":4,"is_preprint":false},{"pmid":"37269349","id":"PMC_37269349","title":"The Potential Role of POR*28 and CYP1A2*F Genetic Variations and Lifestyle Factors on Clozapine and N-DesmethylClozapine Plasma Levels in Schizophrenia Patients.","date":"2023","source":"Expert opinion on drug metabolism & toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/37269349","citation_count":4,"is_preprint":false},{"pmid":"18630181","id":"PMC_18630181","title":"[Antley-Bixler syndrome or POR deficiency?].","date":"2008","source":"Casopis lekaru ceskych","url":"https://pubmed.ncbi.nlm.nih.gov/18630181","citation_count":4,"is_preprint":false},{"pmid":"33666875","id":"PMC_33666875","title":"POR polymorphisms are associated with 21 hydroxylase deficiency.","date":"2021","source":"Journal of endocrinological investigation","url":"https://pubmed.ncbi.nlm.nih.gov/33666875","citation_count":4,"is_preprint":false},{"pmid":"31857256","id":"PMC_31857256","title":"Association of POR and PPARα polymorphisms with risk of anti-tuberculosis drug-induced liver injury in Western Chinese Han population.","date":"2019","source":"Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/31857256","citation_count":4,"is_preprint":false},{"pmid":"23554636","id":"PMC_23554636","title":"Effects of heme precursors on CYP1A2 and POR expression in the baculovirus/Spodoptera frugiperda system.","date":"2010","source":"Journal of biomedical research","url":"https://pubmed.ncbi.nlm.nih.gov/23554636","citation_count":4,"is_preprint":false},{"pmid":"37126018","id":"PMC_37126018","title":"Cytochrome P450 Oxidoreductase (POR) Associated with Severe Paclitaxel-Induced Peripheral Neuropathy in Patients of European Ancestry from ECOG-ACRIN E5103.","date":"2023","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/37126018","citation_count":4,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54342,"output_tokens":4520,"usd":0.115413,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":12604,"output_tokens":3992,"usd":0.08141,"stage2_stop_reason":"end_turn"},"total_usd":0.196823,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2020,\n      \"finding\": \"POR (NADPH-cytochrome P450 reductase) transfers electrons from NADPH to oxygen to generate hydrogen peroxide, which reacts with iron to produce reactive hydroxyl radicals that peroxidize polyunsaturated fatty acid chains of membrane phospholipids, causing membrane disruption during ferroptosis. Genetic knockout of POR decreases cellular hydrogen peroxide generation, preventing lipid peroxidation and ferroptosis. POR knockdown in mouse liver also prevents ConA-induced liver damage.\",\n      \"method\": \"Genetic knockout (CRISPR), hydrogen peroxide measurement, lipid peroxidation assays, mouse liver knockdown model\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (genetic KO, biochemical H2O2 assay, lipid peroxidation, in vivo mouse model), replicated mechanistic pathway\",\n      \"pmids\": [\"33321093\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"POR (NADPH-cytochrome P450 reductase) and CYB5R1 oxidoreductases directly peroxidize PUFA phospholipids in protein-free liposomes in a cell-free reconstitution assay, demonstrating intrinsic enzymatic capacity for lipid oxidation independent of cellular context.\",\n      \"method\": \"Cell-free liposome assay, Tb3+ liposome release, electron microscopy\",\n      \"journal\": \"STAR protocols\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with purified components in defined liposome system, confirming mechanistic finding from PMID 33321093\",\n      \"pmids\": [\"33718888\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"Human NADPH-cytochrome P450 oxidoreductase (POR/CYPOR) encodes a 677 amino acid microsomal protein; vaccinia virus-expressed POR was enzymatically active in reducing cytochrome c and stimulated CYP3 (P450)-mediated ethoxycoumarin O-deethylase and aryl hydrocarbon hydroxylase activities when co-expressed with human CYP3. The CYPOR gene was mapped to chromosome 7 (7p15-q35).\",\n      \"method\": \"Vaccinia virus heterologous expression, cytochrome c reduction assay, co-infection enzymatic assay, somatic cell hybrid mapping\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct enzymatic reconstitution with expressed protein; functional CYP stimulation demonstrated in co-infected cells\",\n      \"pmids\": [\"2501655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Compound heterozygous loss-of-function mutations in POR (including R454H in the FAD-binding domain) cause Antley-Bixler syndrome with impaired steroidogenesis, demonstrating that POR is the obligate electron donor for multiple steroidogenic P450 enzymes (17α-hydroxylase, 17,20-lyase, 21-hydroxylase, lanosterol 14α-demethylase).\",\n      \"method\": \"Direct sequencing of patient DNA, identification of mutations in FAD-binding domain, clinical phenotype-genotype correlation\",\n      \"journal\": \"American journal of medical genetics. Part A\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — human genetics with functional domain annotation; mechanism inferred from conserved FAD-binding domain disruption and clinical steroidogenesis defects; single study without in vitro reconstitution\",\n      \"pmids\": [\"15264278\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"POR transports electrons from NADPH to all microsomal cytochrome P450 enzymes including steroidogenic P450c17, P450c21 and P450aro. Characterization of ~40 POR variants showed that assays based on P450c17 activities (but not cytochrome c assays) correlate with clinical ABS phenotype. The common A503V variant reduces P450c17 activity to ~60% of wild-type. Q153R causes ABS and has ~30% WT activity with P450c17 but 144% with CYP1A2 and 284% with CYP2C19, demonstrating substrate-specific activity differences. A287P and R457H dramatically reduce CYP3A4-mediated drug metabolism.\",\n      \"method\": \"In vitro enzyme activity assays with purified recombinant POR variants, multiple substrate assays (cytochrome c, P450c17, CYP1A2, CYP2C19, CYP3A4)\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic in vitro reconstitution of ~40 variants with multiple P450 substrates; mutagenesis plus functional assays in single rigorous study\",\n      \"pmids\": [\"21070833\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Neutron reflectometry of POR in nanodiscs revealed two distinct conformational states: a compact form (44 Å thick) and an extended form (79 Å thick). Upon complete reduction by NADPH, the equilibrium shifts toward the compact form, protecting the reduced FMN cofactor from non-specific electron transfer.\",\n      \"method\": \"Neutron reflectometry, nanodisc reconstitution, NADPH reduction\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — structural method (neutron reflectometry) with functional validation (NADPH-dependent conformational shift), single lab study\",\n      \"pmids\": [\"22891242\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Crystal structure of a CYPOR-HMOX1 fusion protein at 3.25 Å resolution revealed that NADP+ binding regulates conformational change in the FAD-binding domain of CYPOR, causing the FMN-binding domain to approach heme-bound HMOX1 and enhance electron-transfer efficiency from FMN to heme.\",\n      \"method\": \"X-ray crystallography (3.25 Å), structural comparison of NADP+-bound vs. NADP+-free forms\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure with functional mechanistic interpretation; single lab but direct structural evidence\",\n      \"pmids\": [\"30883732\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The novel POR R550W mutation causes near-complete loss of CYP19A1 (aromatase) activity, >95% loss of CYP17A1 and CYP21A2 activities, and significant loss of CYP2C9, CYP2C19, and CYP3A4 activities. R550W-POR showed 41% of WT cytochrome c reduction and 7.7% MTT reduction activity; reduced NADPH binding was also confirmed.\",\n      \"method\": \"Recombinant protein expression, cytochrome c reduction assay, MTT reduction, multiple P450 activity assays, NADPH binding measurement\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with multiple P450 substrates and binding assay; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"32060549\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"POR knockout mice (Por-/-) exhibit early embryonic lethality (E9.5) associated with elevated and ectopic retinoic acid (RA) signaling. Compound Por-/-; Raldh2+/- mutants (reduced RA synthesis) survived to E13.5, rescuing brain patterning and vascular defects. Limb and caudal defects in these compound mutants phenocopied Cyp26a1-/- and Cyp26b1-/- mutants, demonstrating that POR function is required for CYP26-mediated RA metabolism during embryogenesis.\",\n      \"method\": \"Mouse knockout genetics, RA-reporter lacZ transgene, genetic epistasis (compound mutants with Raldh2 haploinsufficiency), serum-free embryo culture\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — epistasis by compound mutants with two independent rescue strategies; phenotype-genotype linked to CYP26 RA-metabolizing activity\",\n      \"pmids\": [\"17126317\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Zinc finger nuclease knockout of POR in HCT116 and SiHa tumor cell lines demonstrated that POR is required for hypoxia-activated prodrug (HAP) activation of the 5-nitroquinoline SN24349, but POR knockout had little or no effect on activation of most other HAPs including TH-302, PR-104A, and SN30000, indicating differential POR-dependence among one-electron reductase substrates.\",\n      \"method\": \"Zinc finger nuclease gene knockout, proteotypic peptide mass spectrometry quantitation, antiproliferative assay, reductive metabolism assay, clonogenic cell killing\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — functional null KO confirmed by mass spectrometry; multiple substrates tested; two cell line backgrounds; multiple orthogonal readouts\",\n      \"pmids\": [\"24196959\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"siRNA-mediated knockdown of POR in McArdle-RH7777 rat hepatoma cells replicates hepatic lipidosis (triglyceride accumulation in lipid droplets) seen in hepatic POR-null mice. CYP51A1 suppression did not cause lipid accumulation, ruling out loss of cholesterol synthesis as the cause. Chenodeoxycholate addition repressed lipid accumulation, suggesting loss of bile acid synthesis and FXR signaling leads to triglyceride accumulation.\",\n      \"method\": \"siRNA knockdown, immunofluorescence lipid droplet staining, triglyceride quantification, pharmacological rescue with chenodeoxycholate\",\n      \"journal\": \"Drug metabolism and disposition\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO/KD with defined cellular phenotype and pharmacological rescue; single lab, two orthogonal approaches\",\n      \"pmids\": [\"21368239\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Knockdown of CYPOR (POR) in osteoblast cell lines decreased expression of Connexin 43 (Cx43) via transcriptional repression, and reduced gap junction intercellular communication (GJIC) and hemichannel activity. Primary osteoblasts from bone-specific Por knockdown mice confirmed decreased Cx43 expression.\",\n      \"method\": \"RNAi knockdown in osteoblast cell lines, promoter luciferase assay, GJIC functional assay, primary osteoblasts from conditional KO mice\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KD with defined cellular phenotype and transcriptional mechanism; confirmed in primary cells from KO mice; single lab\",\n      \"pmids\": [\"21726529\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Proper membrane association of POR with etioplast inner membranes (prolamellar bodies and prothylakoids) requires NADPH and hydrolysable ATP but not the transit peptide. A mutation in the nucleotide-binding site (ALA06) abolished NADPH-dependent membrane binding, and a substrate-binding site mutation (ALA24) reduced binding, demonstrating that cofactor interaction is essential for membrane association.\",\n      \"method\": \"In vitro-expressed radiolabelled POR, membrane binding assay, site-directed mutagenesis, thermolysin/NaOH/carbonate protection assays\",\n      \"journal\": \"The Plant journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with mutagenesis; single lab; plant ortholog\",\n      \"pmids\": [\"11532175\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Site-directed mutagenesis of multiple active site residues in POR (predicted to interact with NADPH or protochlorophyllide based on homology modeling) profoundly affected photochemistry, identifying residues critical for stabilizing the excited state required for light-driven catalysis.\",\n      \"method\": \"Active-site mutagenesis, static and time-resolved spectroscopy, homology modeling\",\n      \"journal\": \"Journal of photochemistry and photobiology. B, Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis with functional spectroscopic readout; single lab; no crystal structure to validate homology model\",\n      \"pmids\": [\"27285815\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The import of PORA precursor into plastids requires the GTP-binding protein Toc33 (but not Toc34). Plastids from ppi1 (Toc33-null) Arabidopsis mutants failed to import pPORA in darkness but imported pPORB, pSSU, and pFd normally, demonstrating a Toc33-specific import pathway for pPORA.\",\n      \"method\": \"Import assay into isolated plastids, genetic mutant (ppi1/Toc33-null), cross-linking, radiolabeled precursor proteins\",\n      \"journal\": \"The Plant journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct import assay with genetic mutant and orthogonal crosslinking; specific for PORA vs PORB discrimination; plant ortholog\",\n      \"pmids\": [\"15773849\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Ferrochelatase 2 (FC2) physically interacts with POR and stabilizes it; disruption of FC2-POR interaction attenuates suppression of ALA synthesis and leads to accumulation of photoreactive protochlorophyllide. FC2 interacts with both POR and the FLU regulator, promoting feedback suppression of glutamyl-tRNA reductase.\",\n      \"method\": \"Biochemical interaction assays, Arabidopsis mutant and complementation lines, co-immunoprecipitation-type analysis\",\n      \"journal\": \"The New phytologist\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical interaction with functional consequence in plant mutants; single lab; plant ortholog\",\n      \"pmids\": [\"37161708\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"POR variants R268W and L577P (identified from gnomAD) expressed as recombinant proteins showed 35–85% decreased enzymatic activity with model substrates and reduced support for CYP3A4, CYP2C9, and CYP2C19 activities when reconstituted in liposomes.\",\n      \"method\": \"Recombinant protein expression in bacteria, enzyme kinetic assays, P450 reconstitution in liposomes\",\n      \"journal\": \"Biomolecules\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro reconstitution with mutagenesis; single lab; two variants tested\",\n      \"pmids\": [\"38136599\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"POR (NADPH-cytochrome P450 oxidoreductase) is a microsomal flavoprotein (containing FAD and FMN) that transfers electrons from NADPH to all microsomal cytochrome P450 enzymes (including steroidogenic CYP17A1, CYP21A2, CYP19A1, and drug-metabolizing CYP3A4, CYP2C9, CYP2C19, CYP1A2) as well as to heme oxygenase; NADP+ binding drives a conformational shift from an extended to a compact state that positions the FMN domain toward redox partners, and POR also catalyzes direct one-electron transfer from NAD(P)H to oxygen generating H2O2, which drives iron-dependent lipid peroxidation of polyunsaturated membrane phospholipids to execute ferroptosis; loss-of-function mutations in the FAD- or NADPH-binding domains impair steroidogenesis (causing P450 oxidoreductase deficiency/Antley-Bixler syndrome), disrupt retinoic acid homeostasis during embryogenesis through reduced CYP26 activity, and in liver lead to triglyceride accumulation through loss of bile acid synthesis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"POR (NADPH-cytochrome P450 oxidoreductase) is a microsomal flavoprotein that serves as the obligate electron donor for the cytochrome P450 system, shuttling reducing equivalents from NADPH to all microsomal P450 enzymes [#2, #4]. The recombinant human protein reduces cytochrome c and, when co-expressed, stimulates P450-mediated drug oxidation, establishing its function as a diffusible reductase partner [#2]. Electron transfer is governed by a cofactor-driven conformational cycle: complete reduction by NADPH shifts the enzyme from an extended toward a compact form that sequesters the reduced FMN [#5], and NADP+ binding to the FAD-binding domain drives the FMN-binding domain toward the heme of a redox partner to enhance electron transfer, as captured in a CYPOR-heme oxygenase fusion structure [#6]. POR supplies electrons across a broad substrate range, supporting steroidogenic P450s (CYP17A1/P450c17, CYP21A2, CYP19A1/aromatase) and drug-metabolizing enzymes (CYP3A4, CYP2C9, CYP2C19, CYP1A2) with substrate-specific efficiencies, such that individual variants can impair some activities while sparing or even enhancing others [#4, #7]. Loss-of-function mutations in the FAD- or NADPH-binding domains cause P450 oxidoreductase deficiency/Antley-Bixler syndrome through disrupted steroidogenesis [#3, #7]. Beyond its P450-coupled role, POR acts as a one-electron reductase that transfers electrons from NADPH to oxygen to generate hydrogen peroxide, which through iron-dependent chemistry peroxidizes polyunsaturated membrane phospholipids to execute ferroptosis — an intrinsic enzymatic capacity reconstituted with purified POR in protein-free liposomes [#0, #1]. In vivo, POR is required for CYP26-mediated retinoic acid metabolism during embryogenesis, with knockout causing embryonic lethality from ectopic retinoic acid signaling [#8], and hepatic POR loss produces triglyceride accumulation attributable to loss of bile acid synthesis [#10].\",\n  \"teleology\": [\n    {\n      \"year\": 1989,\n      \"claim\": \"Established that the cloned human POR gene encodes an enzymatically active reductase that functionally couples to cytochrome P450, defining its core role as a P450 electron donor.\",\n      \"evidence\": \"Vaccinia virus heterologous expression, cytochrome c reduction, and co-infection P450 enzymatic assays, with chromosomal mapping to 7p15-q35\",\n      \"pmids\": [\"2501655\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve the structural basis of electron transfer\", \"Tested with limited P450 substrates\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Linked POR loss-of-function directly to human disease, showing it is the obligate electron donor for multiple steroidogenic P450s.\",\n      \"evidence\": \"Patient DNA sequencing identifying compound heterozygous FAD-domain mutations (e.g. R454H) in Antley-Bixler syndrome with steroidogenesis defects\",\n      \"pmids\": [\"15264278\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism inferred from domain annotation without in vitro reconstitution\", \"Single study\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrated that POR variants confer substrate-specific changes in P450 support, explaining why cytochrome c assays poorly predict clinical phenotype.\",\n      \"evidence\": \"In vitro reconstitution of ~40 recombinant POR variants assayed against cytochrome c, P450c17, CYP1A2, CYP2C19 and CYP3A4\",\n      \"pmids\": [\"21070833\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not map activity differences to defined structural states\", \"In vitro activities not validated against in vivo steroid output for all variants\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Resolved how cofactor reduction controls POR conformation, defining a structural mechanism that protects the reduced FMN.\",\n      \"evidence\": \"Neutron reflectometry of nanodisc-reconstituted POR before and after NADPH reduction, revealing compact and extended states\",\n      \"pmids\": [\"22891242\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Single lab method\", \"Did not capture the partner-bound state\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Provided atomic-level evidence that NADP+ binding repositions the FMN domain toward the redox partner to drive electron transfer.\",\n      \"evidence\": \"X-ray crystallography (3.25 A) of a CYPOR-HMOX1 fusion comparing NADP+-bound and free states\",\n      \"pmids\": [\"30883732\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Captured with heme oxygenase rather than a P450 partner\", \"Single structure of a fusion construct\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Established an in vivo developmental requirement for POR in retinoic acid homeostasis via CYP26 enzymes.\",\n      \"evidence\": \"Por knockout mouse genetics with RA-reporter readout and genetic epistasis using Raldh2 haploinsufficiency and phenocopy of Cyp26 mutants\",\n      \"pmids\": [\"17126317\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Embryonic lethality limits analysis of later roles\", \"Does not isolate CYP26 from other P450 contributions to the full phenotype\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Connected hepatic POR loss to triglyceride accumulation through loss of bile acid synthesis rather than cholesterol synthesis.\",\n      \"evidence\": \"siRNA knockdown in rat hepatoma cells, lipid droplet staining, triglyceride quantification, and chenodeoxycholate rescue, with CYP51A1 control\",\n      \"pmids\": [\"21368239\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"FXR-signaling link inferred from pharmacological rescue\", \"Single lab in vitro system\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identified a P450-independent role for POR in regulating osteoblast gap junction communication.\",\n      \"evidence\": \"RNAi knockdown in osteoblast lines with Cx43 promoter luciferase, GJIC assay, and primary osteoblasts from bone-specific KO mice\",\n      \"pmids\": [\"21726529\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Transcriptional mechanism linking POR to Cx43 not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Established POR as a determinant of hypoxia-activated prodrug activation with substrate selectivity among one-electron reductase substrates.\",\n      \"evidence\": \"Zinc finger nuclease knockout in HCT116 and SiHa cells with mass-spectrometry-confirmed null status and multiple prodrug activation readouts\",\n      \"pmids\": [\"24196959\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not identify the reductases responsible for POR-independent prodrugs\", \"Two tumor cell backgrounds only\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Defined POR as a driver of ferroptosis through NADPH-dependent generation of hydrogen peroxide that fuels lipid peroxidation.\",\n      \"evidence\": \"CRISPR knockout, H2O2 measurement, lipid peroxidation assays, and a ConA-induced mouse liver knockdown model\",\n      \"pmids\": [\"33321093\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of POR versus other oxidoreductases to ferroptosis in different tissues unresolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Confirmed that POR has intrinsic enzymatic capacity to peroxidize PUFA phospholipids independent of cellular context.\",\n      \"evidence\": \"Cell-free reconstitution with purified POR (and CYB5R1) in protein-free liposomes using Tb3+ release and electron microscopy\",\n      \"pmids\": [\"33718888\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not quantify in vivo contribution relative to enzymatic context\", \"Protocol-format report\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Extended the genotype-phenotype map by characterizing a variant (R550W) that ablates aromatase and most steroidogenic and drug-metabolizing P450 support.\",\n      \"evidence\": \"Recombinant protein with cytochrome c and MTT reduction, multiple P450 activity assays, and NADPH binding measurement\",\n      \"pmids\": [\"32060549\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Single variant\", \"In vitro activities not linked to clinical outcome in this study\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Characterized additional population variants confirming reduced P450 support, broadening the spectrum of functionally impaired POR alleles.\",\n      \"evidence\": \"Recombinant expression of gnomAD-derived R268W and L577P with enzyme kinetics and liposome P450 reconstitution\",\n      \"pmids\": [\"38136599\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Two variants only\", \"Single lab, no in vivo validation\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how POR's conformational cycle, partner selectivity, and one-electron oxygen-reductase activity are coordinated to partition between productive P450 catalysis and ferroptotic lipid peroxidation in specific tissues.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structure of POR bound to a steroidogenic P450 partner\", \"Tissue-specific control of P450 coupling versus H2O2 generation undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [0, 1, 2, 4, 7]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [2, 4, 6, 7]},\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0, 2, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [2, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [3, 4, 10]},\n      {\"term_id\": \"R-HSA-9748784\", \"supporting_discovery_ids\": [4, 9, 16]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"HMOX1\", \"CYP17A1\", \"CYP21A2\", \"CYP19A1\", \"CYP3A4\", \"CYP2C9\", \"CYP2C19\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}